Absci Corporation
NASDAQABSI has ripped 56% in a single week to $11.59, yet the shorts have barely moved — setting up one of the more telling standoffs in small-cap biotech right now. The short position is stubbornly large. Short interest climbed roughly 9.7% over the week to 22.3% of the free float — around 33.6 million shares — even as the stock was tearing higher. That is not a squeeze unwind. Shorts…
Snapshot as of 9 Aug 2026
ABSI has ripped 56% in a single week to $11.59, yet the shorts have barely moved — setting up one of the more telling standoffs in small-cap biotech right now. The short position is stubbornly large. Short interest…
ABSI heads into the final days of June with a jarring contradiction: the stock fell nearly 12% on Tuesday while the Street is busily raising price targets to levels well above the current price. The analyst tone has…
Absci Corporation heads into its June 4 earnings report with short sellers in measured retreat and an analyst upgrade providing fresh upside context — while options traders turned their most call-heavy in months. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ABSI — free to start on ORTEX.
Sign up for free →Open ABSI on ORTEX